SCN1A mutation spectrum in a cohort of Bulgarian patients with GEFS+ phenotype
Background. Dravet syndrome (DS) is the most severe form of Generalized Epilepsy with Febrile Seizures plus (GEFS+) syndrome with a clear genetic component in 85% of the cases. It is characterized by fever-provoked seizure onset around six months of age and subsequent developmental deteriorat...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hacettepe University Institute of Child Health
2020-10-01
|
| Series: | The Turkish Journal of Pediatrics |
| Subjects: | |
| Online Access: | https://turkjpediatr.org/article/view/506 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850042222392639488 |
|---|---|
| author | Valentina Peycheva Elena Rodopska Elena Slavkova Iliyana Aleksandrova Emil Simeonov Petia Dimova Veneta Bojinova Vanyo Mitev Albena Jordanova Daniela Deneva Dimitrina Hristova Ivan Litvinenko Nevyana Ivanova Kunka Kamenarova Margarita Panova Iliana Pacheva Ivan Ivanov Maria Bojidarova Genoveva Tacheva Dimitar Stamatov Radka Kaneva |
| author_facet | Valentina Peycheva Elena Rodopska Elena Slavkova Iliyana Aleksandrova Emil Simeonov Petia Dimova Veneta Bojinova Vanyo Mitev Albena Jordanova Daniela Deneva Dimitrina Hristova Ivan Litvinenko Nevyana Ivanova Kunka Kamenarova Margarita Panova Iliana Pacheva Ivan Ivanov Maria Bojidarova Genoveva Tacheva Dimitar Stamatov Radka Kaneva |
| author_sort | Valentina Peycheva |
| collection | DOAJ |
| description |
Background. Dravet syndrome (DS) is the most severe form of Generalized Epilepsy with Febrile Seizures plus (GEFS+) syndrome with a clear genetic component in 85% of the cases. It is characterized by fever-provoked seizure onset around six months of age and subsequent developmental deterioration later in life.
Methods. In the current study, 60 patients with fever-provoked seizures and suspicion either of GEFS+ (50 patients) or of DS (10 patients) were referred for SCN1A gene sequence analysis.
Results. SCN1A gene sequencing revealed clinically significant variants in 11 patients (18.3%); seven pathogenic (11.7%) and four likely pathogenic (6.7%). Five of these variants have not been reported previously. Among the preselected group of ten DS patients, five had pathogenic SCN1A variants which confirmed diagnosis of DS. In four patients with preliminary diagnosis GEFS+, the detected SCN1A variant enabled us to specify the diagnosis of DS in these patients. Thus, SCN1A sequencing led to confirmation of the genetic diagnosis in 50% (5/10) of DS patients, as well as clarification of the diagnosis of DS in 8% of GEFS+ patients (4/50). In this study, four patients with truncating mutations had refractory seizures and additional psychomotor abnormalities. Additionally, pathogenic missense mutations were detected in three children with comparable phenotypes, which support the observations that missense mutations in critical channel function regions can cause a devastating epileptic condition.
Conclusions. This is the first systematic screening of SCN1A gene in our country, which expands the spectrum of SCN1A variants with five novel variants from Bulgaria and demonstrates the clinical utility of confirmatory SCN1A testing, which helps clinicians make early and precise diagnoses. It is important for a better followup, choice of proper treatment, avoidance of development of refractory seizures and neuropsychological complications. Identification of pathogenic variants in SCN1A in the milder GEFS+ and severe DS cases, will help to offer adequate prenatal diagnosis and improve the genetic counselling provided to affected families.
|
| format | Article |
| id | doaj-art-8f4347ebf17a4df4b3eb30fcb5cb3a4f |
| institution | DOAJ |
| issn | 0041-4301 2791-6421 |
| language | English |
| publishDate | 2020-10-01 |
| publisher | Hacettepe University Institute of Child Health |
| record_format | Article |
| series | The Turkish Journal of Pediatrics |
| spelling | doaj-art-8f4347ebf17a4df4b3eb30fcb5cb3a4f2025-08-20T02:55:38ZengHacettepe University Institute of Child HealthThe Turkish Journal of Pediatrics0041-43012791-64212020-10-0162510.24953/turkjped.2020.05.002SCN1A mutation spectrum in a cohort of Bulgarian patients with GEFS+ phenotypeValentina Peycheva0Elena Rodopska1Elena Slavkova2Iliyana Aleksandrova3Emil Simeonov4Petia Dimova5Veneta Bojinova6Vanyo Mitev7Albena JordanovaDaniela Deneva8Dimitrina Hristova9Ivan Litvinenko10Nevyana Ivanova11Kunka Kamenarova12Margarita Panova13Iliana Pacheva14Ivan Ivanov15Maria Bojidarova16Genoveva Tacheva17Dimitar Stamatov18Radka Kaneva19Department of Medical Chemistry and Biochemistry, Molecular Medicine Center, Medical University-Sofia, Sofia, Bulgaria.Department of Neurology, University Hospital of Neurology and Psychiatry "St' Naum", Clinic of Child Neurology, Medical University-Sofia, Sofia, Bulgaria.Department of Neurology, University Hospital of Neurology and Psychiatry "St' Naum", Clinic of Child Neurology, Medical University-Sofia, Sofia, Bulgaria.Department of Neurology, University Hospital of Neurology and Psychiatry "St' Naum", Clinic of Child Neurology, Medical University-Sofia, Sofia, Bulgaria.University Hospital.Epilepsy Surgery Center, University Hospital "St. Ivan Rilski", Medical University-Sofia, Sofia, Bulgaria.Department of Neurology, University Hospital of Neurology and Psychiatry "St' Naum", Clinic of Child Neurology, Medical University-Sofia, Sofia, Bulgaria.Department of Medical Chemistry and Biochemistry, Molecular Medicine Center, Medical University-Sofia, Sofia, Bulgaria.Department of Neurology, University Hospital of Neurology and Psychiatry "St' Naum", Clinic of Child Neurology, Medical University-Sofia, Sofia, Bulgaria.Pediatrics Clinic, Acibadem City Clinic Tokuda Hospital, Sofia, Bulgaria.Department of Pediatric Neurology, University Pediatrics Hospital, Medical University- Sofia, Sofia, Bulgaria; Children Neurology Unit.Department of Medical Chemistry and Biochemistry, Molecular Medicine Center, Medical University-Sofia, Sofia, Bulgaria.Department of Medical Chemistry and Biochemistry, Molecular Medicine Center, Medical University-Sofia, Sofia, Bulgaria.Department of Pediatrics and Medical Genetics, Medical Faculty, Medical University-Plovdiv, Plovdiv, Bulgaria.Department of Pediatrics and Medical Genetics, Medical Faculty, Medical University-Plovdiv, Plovdiv, Bulgaria.Department of Pediatrics and Medical Genetics, Medical Faculty, Medical University-Plovdiv, Plovdiv, Bulgaria.Department of Pediatric Neurology, University Pediatrics Hospital, Medical University- Sofia, Sofia, Bulgaria; Children Neurology Unit.Department of Pediatric Neurology, University Pediatrics Hospital, Medical University- Sofia, Sofia, Bulgaria; Children Neurology Unit.Department of Pediatric Neurology, University Pediatrics Hospital, Medical University- Sofia, Sofia, Bulgaria; Children Neurology Unit.Department of Medical Chemistry and Biochemistry, Molecular Medicine Center, Medical University-Sofia, Sofia, Bulgaria. Background. Dravet syndrome (DS) is the most severe form of Generalized Epilepsy with Febrile Seizures plus (GEFS+) syndrome with a clear genetic component in 85% of the cases. It is characterized by fever-provoked seizure onset around six months of age and subsequent developmental deterioration later in life. Methods. In the current study, 60 patients with fever-provoked seizures and suspicion either of GEFS+ (50 patients) or of DS (10 patients) were referred for SCN1A gene sequence analysis. Results. SCN1A gene sequencing revealed clinically significant variants in 11 patients (18.3%); seven pathogenic (11.7%) and four likely pathogenic (6.7%). Five of these variants have not been reported previously. Among the preselected group of ten DS patients, five had pathogenic SCN1A variants which confirmed diagnosis of DS. In four patients with preliminary diagnosis GEFS+, the detected SCN1A variant enabled us to specify the diagnosis of DS in these patients. Thus, SCN1A sequencing led to confirmation of the genetic diagnosis in 50% (5/10) of DS patients, as well as clarification of the diagnosis of DS in 8% of GEFS+ patients (4/50). In this study, four patients with truncating mutations had refractory seizures and additional psychomotor abnormalities. Additionally, pathogenic missense mutations were detected in three children with comparable phenotypes, which support the observations that missense mutations in critical channel function regions can cause a devastating epileptic condition. Conclusions. This is the first systematic screening of SCN1A gene in our country, which expands the spectrum of SCN1A variants with five novel variants from Bulgaria and demonstrates the clinical utility of confirmatory SCN1A testing, which helps clinicians make early and precise diagnoses. It is important for a better followup, choice of proper treatment, avoidance of development of refractory seizures and neuropsychological complications. Identification of pathogenic variants in SCN1A in the milder GEFS+ and severe DS cases, will help to offer adequate prenatal diagnosis and improve the genetic counselling provided to affected families. https://turkjpediatr.org/article/view/506Dravet syndromeGEFS+SCN1A mutationseizures |
| spellingShingle | Valentina Peycheva Elena Rodopska Elena Slavkova Iliyana Aleksandrova Emil Simeonov Petia Dimova Veneta Bojinova Vanyo Mitev Albena Jordanova Daniela Deneva Dimitrina Hristova Ivan Litvinenko Nevyana Ivanova Kunka Kamenarova Margarita Panova Iliana Pacheva Ivan Ivanov Maria Bojidarova Genoveva Tacheva Dimitar Stamatov Radka Kaneva SCN1A mutation spectrum in a cohort of Bulgarian patients with GEFS+ phenotype The Turkish Journal of Pediatrics Dravet syndrome GEFS+ SCN1A mutation seizures |
| title | SCN1A mutation spectrum in a cohort of Bulgarian patients with GEFS+ phenotype |
| title_full | SCN1A mutation spectrum in a cohort of Bulgarian patients with GEFS+ phenotype |
| title_fullStr | SCN1A mutation spectrum in a cohort of Bulgarian patients with GEFS+ phenotype |
| title_full_unstemmed | SCN1A mutation spectrum in a cohort of Bulgarian patients with GEFS+ phenotype |
| title_short | SCN1A mutation spectrum in a cohort of Bulgarian patients with GEFS+ phenotype |
| title_sort | scn1a mutation spectrum in a cohort of bulgarian patients with gefs phenotype |
| topic | Dravet syndrome GEFS+ SCN1A mutation seizures |
| url | https://turkjpediatr.org/article/view/506 |
| work_keys_str_mv | AT valentinapeycheva scn1amutationspectruminacohortofbulgarianpatientswithgefsphenotype AT elenarodopska scn1amutationspectruminacohortofbulgarianpatientswithgefsphenotype AT elenaslavkova scn1amutationspectruminacohortofbulgarianpatientswithgefsphenotype AT iliyanaaleksandrova scn1amutationspectruminacohortofbulgarianpatientswithgefsphenotype AT emilsimeonov scn1amutationspectruminacohortofbulgarianpatientswithgefsphenotype AT petiadimova scn1amutationspectruminacohortofbulgarianpatientswithgefsphenotype AT venetabojinova scn1amutationspectruminacohortofbulgarianpatientswithgefsphenotype AT vanyomitev scn1amutationspectruminacohortofbulgarianpatientswithgefsphenotype AT albenajordanova scn1amutationspectruminacohortofbulgarianpatientswithgefsphenotype AT danieladeneva scn1amutationspectruminacohortofbulgarianpatientswithgefsphenotype AT dimitrinahristova scn1amutationspectruminacohortofbulgarianpatientswithgefsphenotype AT ivanlitvinenko scn1amutationspectruminacohortofbulgarianpatientswithgefsphenotype AT nevyanaivanova scn1amutationspectruminacohortofbulgarianpatientswithgefsphenotype AT kunkakamenarova scn1amutationspectruminacohortofbulgarianpatientswithgefsphenotype AT margaritapanova scn1amutationspectruminacohortofbulgarianpatientswithgefsphenotype AT ilianapacheva scn1amutationspectruminacohortofbulgarianpatientswithgefsphenotype AT ivanivanov scn1amutationspectruminacohortofbulgarianpatientswithgefsphenotype AT mariabojidarova scn1amutationspectruminacohortofbulgarianpatientswithgefsphenotype AT genovevatacheva scn1amutationspectruminacohortofbulgarianpatientswithgefsphenotype AT dimitarstamatov scn1amutationspectruminacohortofbulgarianpatientswithgefsphenotype AT radkakaneva scn1amutationspectruminacohortofbulgarianpatientswithgefsphenotype |